Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Levodopa
by Most Market Reports in the United Kingdom in 2021

The Levodopa top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Market Reports Levodopa Key Players in the United Kingdom. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
l-DOPA, also known as levodopa and l-3,4-dihydroxyphenylalanine, is an amino acid that is made and used as part of the normal biology of humans, as well as some animals and plants. Humans, as well as a portion of the other animals that utilize l-DOPA in their biology, make it via biosynthesis from the amino acid l-tyrosine. l-DOPA is the precursor to the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline), which are collectively known as catecholamines. Furthermore, l-DOPA itself mediates neurotrophic factor release by the brain and CNS. l-DOPA can be manufactured and in its pure form is sold as a psychoactive drug with the INN levodopa; trade names include Sinemet, Pharmacopa, Atamet, Stalevo, Madopar, and Prolopa. As a drug, it is used in the clinical treatment of Parkinson's disease and dopamine-responsive dystonia.
#
Company Name
Region
Tech Topics
Total
1
GSK Plc
Health care,Clinical trial,Drug,
...[+2]
market report: 16
2
Mylan NV
Transdermal patch,Medicine,Pharmacy,
...[+2]
market report: 7
3
AstraZeneca Plc
Medicine,Health care,Side effect,
...[+2]
market report: 4
4
Impax Asset Management Group Plc
Asset management,Anticholinergic,Levodopa,
...[+2]
market report: 2
5
Britannia Pharmaceuticals Ltd.
Subcutaneous injection,Levodopa,Neurology,
...[+2]
market report: 2
6
Imperial Brands Plc
Nicotiana tabacum,Fast-moving consumer goods,Cigarillo,
...[+2]
market report: 1
7
Watches of Switzerland Group Plc
Precious metal
market report: 1
8
Oxford Biomedica Plc
Cell therapy,Process development,Medicine,
...[+2]
market report: 1
9
Scottish Enterprise
Venture capital,Biomedicine,Biotechnology,
...[+2]
market report: 1
10
Cobra Biologics Ltd.
Clinical trial,Biology,Monoclonal antibody,
...[+2]
market report: 1
11
Genomia Management Ltd.
Public sector,Asset management,Apomorphine,
...[+2]
market report: 1
12
Hammersmith Medicines Research Ltd.
Clinical trial,Health care,Biotechnology,
...[+2]
market report: 1
13
MISSION Therapeutics Ltd.
Enzyme,Health care,Drug target,
...[+2]
market report: 1
14
Albania Properties Ltd.
Antibiotics,Gastrointestinal agent,Feed additive,
...[+2]
market report: 1
15
BenevolentAI Ltd.
Software,Artificial intelligence,Drug discovery,
...[+2]
market report: 1
16
Antoxis Ltd.
Health care,Apomorphine,Safinamide,
...[+2]
market report: 1
17
Grampian Biopartners Ltd.
Impact investing,Asset management,Apomorphine,
...[+2]
market report: 1
18
Dementia Discovery Fund
Dementia,Venture capital,Biomedicine,
...[+2]
market report: 1
19
Kapital Assets Ltd.
Real estate development,Apomorphine,Safinamide,
...[+1]
market report: 1
20
Otsuka Pharmaceuticals (U.K.) Ltd.
Medicine,Venlafaxine,Escitalopram,
...[+2]
market report: 1
Page generation time: Oct 01 2025